Home » Topics » Disease categories and therapies » Ear, nose and throat

Ear, nose and throat
RSS

Initiation of phase I/II study of OTO-313 in patients with tinnitus

April 12, 2019

Frequency Therapeutics reports phase I/II data on FX-322 for hearing restoration

April 9, 2019

Hearing loss gene therapy works in adult mice

March 12, 2019

Novel dual AAV-mediated gene therapy shows efficacy in DFNB9 mouse model

Feb. 26, 2019

Positive results announced from phase I study of LY-3056480 in sensorineural hearing loss

Feb. 7, 2019

Sound Pharmaceuticals enrolls first patient in STOP Ototoxicity phase II study of SPI-1005

Jan. 15, 2019

Spiral Therapeutics initiates phase I trial of new hearing loss drug, LPT-99

Dec. 19, 2018

Seliforant shown not to affect vigilance, cognitive performance during motion stimulus

Dec. 14, 2018

Novus initiates phase I trial of OP-0201 for otitis media

Nov. 29, 2018

Sensorion signs letter of intent with Institut Pasteur for hearing loss gene therapy programs

Nov. 23, 2018

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 30, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 30, 2026.
Brain-derived tau in blood predicts stroke severity and outcome
BioWorld Science
Brain-derived tau, a protein that is exclusive to the brain and detectable in the blood, could serve as an indicator of brain damage after an ischemic stroke. The...
Centessa’s CNT-9982 shows promise for MDD
BioWorld Science
Orexin OX2 receptor agonists have demonstrated the ability to enhance wakefulness in rodent models, as well as in nonhuman primates and patients with narcolepsy...
First-in-class ADC targeting DEM-TXX shows high preclinical efficacy
BioWorld Science
Researchers at DEM Biopharma Inc. reported preclinical findings demonstrating the efficacy of DEM-301, a bifunctional antibody-drug conjugate (ADC) engineered to...